RxDoctor Payments Data

Jessica Szpak, PA

Physician Assistant · Baraboo, WINPI 1528297744

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $58,186 of the $95,149 with a category attached, or 61.2%. 6 manufacturers reported payments, led by TG Therapeutics, Inc. at 32.3% of the total. Among physician assistant clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,149in general payments, 2019–2025

Across 130 payments — averaging $731.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TG Therapeutics, Inc.$31K
  • Sanofi$21K
  • Biogen$20K
  • EMD Serono, Inc.$18K
  • Genentech USA, Inc.$4K
  • Bristol Myers Squibb$2K

What the payments were for

  • Consulting fees$29,46931%
  • Speaking & faculty fees$58,18661%
  • Travel & lodging$5,1385%
  • Food & beverage$2,0682%
  • Education$2880%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
TG Therapeutics, Inc.43$30,703
Sanofi27$20,686
Biogen26$19,965
EMD Serono, Inc.23$17,647
Genentech USA, Inc.7$4,270
Bristol Myers Squibb4$1,880

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$95,149 in reported general payments places this provider in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Medicare billing

Part B allowed, 2024
$93,594
Medicare patients
122
Services billed
1,545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Avonex Pen (4 Pack)Interferon Beta-1a32$259,162
Kesimpta PenOfatumumab23$223,673
CopaxoneGlatiramer Acetate24$145,348
Glatiramer Acetate46$105,849
VumerityDiroximel Fumarate12$91,624
FingolimodFingolimod Hcl13$87,314
GlatopaGlatiramer Acetate57$81,049
Teriflunomide136$60,226
TecfideraDimethyl Fumarate13$37,602
Dimethyl Fumarate164$31,986
Emgality PenGalcanezumab-Gnlm37$26,242
Aimovig AutoinjectorErenumab-Aooe24$17,786
Dalfampridine ErDalfampridine119$17,233
Emgality SyringeGalcanezumab-Gnlm11$7,732
Baclofen134$5,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BiogenVumerity, Tecfidera$19,965$129,22625 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Baraboo

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →